TITLE

Prognostic Markers and Gene Abnormalities in Subgroups of Diffuse Large B-cell Lymphoma: Single Center Experience

PUB. DATE
October 2008
SOURCE
Croatian Medical Journal;2008, Vol. 49 Issue 5, p618
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
35116126

 

Related Articles

  • Diffuse Large B-Cell Lymphoma. Hunt, Kristin E.; Reichard, Kaaren K. // Archives of Pathology & Laboratory Medicine;Jan2008, Vol. 132 Issue 1, p118 

    Diffuse large B-cell lymphoma is the most common lymphoma worldwide. Both morphologically and prognostically it represents a diverse spectrum of disease. Traditional morphologic subclassification often results in poor interobserver reproducibility and has not been particularly helpful in...

  • Clinicopathologic implications of tissue inhibitor of metalloproteinase-1-positive diffuse large B-cell lymphoma. Jung-Woo Choi; Jung-Suk An; Ju-Han Lee; Eung-Seok Lee; Kwang Hee Kim; Young-Sik Kim // Modern Pathology;Jul2006, Vol. 19 Issue 7, p963 

    The tissue inhibitor of metalloproteinase-1 (TIMP-1) is a stromal factor that promotes plasmablastic differentiation, and the survival of germinal center B-cells. The expression of TIMP-1 is known to be correlated with a subset of non-Hodgkin lymphoma at the mRNA level, and Epstein–Barr...

  • The contribution of HGAL/GCET2 in immunohistological algorithms: a comparative study in 424 cases of nodal diffuse large B-cell lymphoma. Gualco, Gabriela; Bacchi, Lívia M; Domeny-Duarte, Pollyanna; Natkunam, Yasodha; Bacchi, Carlos E // Modern Pathology;Nov2012, Vol. 25 Issue 11, p1439 

    No abstract available.

  • Colorimetric In Situ Hybridization Identifies MYC Gene Signal Clusters Correlating With Increased Copy Number, mRNA, and Protein in Diffuse Large B-Cell Lymphoma. Valentino, Carlo; Kendrick, Samantha; Johnson, Nathalie; Gascoyne, Randy; Chan, Wing C.; Weisenburger, Dennis; Braziel, Rita; Cook, James R.; Tubbs, Raymond; Campo, Elias; Rosenwald, Andreas; Ott, German; Delabie, Jan; Jaffe, Elaine; Wenjun Zhang; Brunhoeber, Patrick; Hiro Nitta; Grogan, Tom; Rimsza, Lisa // American Journal of Clinical Pathology;Feb2013, Vol. 139 Issue 2, p242 

    Abnormalities of the MYC oncogene on chromosome 8 are characteristic of Burkitt lymphoma and other aggressive B-cell lymphomas, including diffuse large B-cell lymphoma (DLBCL). We recently described a colorimetric in situ hybridization (CISH) method for detecting extra copies of the MYC gene in...

  • Cytogenetics and molecular cytogenetics in diffuse large B-cell lymphoma (DLBCL). Nedomova, Radka; Papajik, Tomas; Prochazka, Vit; Indrak, Karel; Jarosova, Marie // Biomedical Papers of the Medical Faculty of Palacky University i;Sep2013, Vol. 157 Issue 3, p239 

    Background. Diffuse large B-cell lymphoma (DLBCL) accounts for up to 40% of all non-Hodgkin's lymphomas diagnosed in the western hemisphere. Determination of the gene expression profile has confirmed the physiological heterogeneity of the disease and defined three molecular prognostic subgroups...

  • AIDS and non-AIDS diffuse large B-cell lymphomas express different antigen profiles. Madan, Rashna; Gormley, Robert; Dulau, Alina; Dongsheng Xu; Walsh, Daniel; Ramesh, K. H.; Cannizaro, Linda; Tamas, Ecaterina F.; Kumar, Pankaj; Sparano, Joseph; LeValley, Aaron; Xiaonan Xue; Bhattacharyya, Pritish K.; Ioachim, Harry L.; Ratech, Howard; Xu, Dongsheng; Xue, Xiaonan // Modern Pathology;Mar2006, Vol. 19 Issue 3, p438 

    Based on gene expression profiling, diffuse large B-cell lymphomas arising in immunocompetent patients can be divided into germinal center and activated B-cell types. Since little is known about acquired immunodeficiency syndrome associated diffuse large B-cell lymphomas, we tested whether the...

  • Antineoplastics.  // Reactions Weekly;Jan2015, Vol. 1533 Issue 1, p53 

    An abstract of the article "How to treat B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma: Single centre experience," by J. Michalka and colleagues is presented.

  • Lymphoma: Biological aspects and prognosis.  // Hematology Journal;2004 Supplement 2, Vol. 5, pS1 

    Presents abstracts of studies on lymphoma, focusing on biological aspects and prognosis. CD10 and BCL-2 expression combined with the International Prognostic Index can identify subgroups of patients with diffuse large-cell lymphoma with very low and very high risk; Comparison of gene expression...

  • Expression of LMO2 Is Associated With t(14;18)/IGH-BCL2 Fusion but Not BCL6 Translocations in Diffuse Large B-Cell Lymphoma. Durnick, David K.; Law, Mark E.; Maurer, Matthew J.; Natkunam, Yasodha; Levy, Ronald; Lossos, Izidore S.; Kurtin, Paul J.; McPhail, Ellen D. // American Journal of Clinical Pathology;Aug2010, Vol. 134 Issue 2, p278 

    Diffuse large B-cell lymphoma (DLBCL) can be separated for prognostic purposes using gene expression profiling (GEP) into 2 subgroups: germinal center B-cell (GCB) and activated B-cell phenotypes. However, GEP is impractical for routine clinical use, and immunophenotyping is an imperfect...

  • Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story. Bari, A.; Marcheselli, L.; Sacchi, S.; Marcheselli, R.; Pozzi, S.; Ferri, P.; Balleari, E.; Musto, P.; Neri, S.; Aloe Spiriti, M. A.; Cox, M. C. // Annals of Oncology;Jul2010, Vol. 21 Issue 7, p1486 

    Background: Improved treatment have modified survival outcome in patients with diffuse large B-cell lymphoma (DLBCL) and altered the importance of previously recognized prognostic markers.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics